AFFIRM-AHF
A randomised, double-blind placebo controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron deficient patients admitted for acute heart failure (AFFIRM-AHF)
- Stage
- klaar
- Medicine
- ferric carboxymaltose
- Population
- Hartfalen
- Phase
- IV
- First Patient In
- 1 June 2017
- Last Patient In
- 19 July 2019
- Last Patient Last Visit
- 31 July 2020
National Lead
dr. P van der Meer
Cardioloog
Study Director
